018564442

---

September 22, 2021

Trademark Summary

The trademark application was filed by Adaptive Phage Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 14, 2021, and it was registered by office on January 21, 2022 without any oppositions.

The application was filed in English (French was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Human, animal, plant and microorganism biological preparations for use in drug development, disease modeling and personalized medicine to prevent or treat bacterial infectious diseases
  2. Bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation
  3. Bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields
  4. None of the aforementioned goods used in manufacturing.
• The mark was filed in class 40 with Custom manufacture of bacteriophage therapeutics.
• The mark was filed in class 42 with following description of goods:
  
  1. Research and development in the fields of personalized medicine and diagnostics
  2. Data mining of healthcare and genetic information in the field of precision medicine and personalized medicine
  3. Scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and/or pharmaceuticals
  4. Clinical and medical laboratory testing services in the fields of disease diagnostics and personalized medicine
  5. Pharmaceutical drug research and development
  6. Custom assay development
  7. Pharmaceutical drug discovery and development services
  8. Providing laboratory research services in the field of medical diagnostics and personalized medicine
  9. Medical research services
  10. Biotechnology research
  11. Providing medical and scientific research information in the field of clinical trials
  12. Research and development of vaccines and therapeutics.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical testing for diagnostic or treatment purposes in the field of personalized medicine
  2. Health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes
  3. Clinical and medical laboratory testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine.